Status:
COMPLETED
Use and Misuse of Domperidone in Parkinson's Disease in France - Dump Investigation
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Parkinson's Disease
Eligibility:
All Genders
Brief Summary
Parkinson disease is the second most frequent neurodegenerative disease after Alzheimer disease and affect 1% of the population over 60 years. The treatment of PD is based on dopamine replacement ther...
Detailed Description
Parkinson disease is the second most frequent neurodegenerative disease after Alzheimer disease and affect 1% of the population over 60 years (150 to 170 000 patients in France). The treatment of PD i...
Eligibility Criteria
Inclusion
- All neurologists in France
Exclusion
- None
Key Trial Info
Start Date :
July 17 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
2300 Patients enrolled
Trial Details
Trial ID
NCT03837067
Start Date
July 17 2018
End Date
December 1 2018
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
La Pitié Salpétrière Hospital
Paris, France, 75013